Cargando…

MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer

Breast cancer treatment can be improved with biomarkers for early detection and individualized therapy. A set of 86 microRNAs (miRNAs) were identified to separate breast cancer tumors from normal breast tissues (n = 52) with an overall accuracy of 90.4%. Six miRNAs had concordant expression in both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Qing, Raese, Rebecca A., Luo, Dajie, Feng, Juan, Xin, Wenjun, Dong, Chunlin, Qian, Yong, Guo, Nancy Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378316/ https://www.ncbi.nlm.nih.gov/pubmed/37508580 http://dx.doi.org/10.3390/cells12141917

Ejemplares similares

MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes
por: Ye, Qing, et al.
Publicado: (2023)

Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data
por: Ye, Qing, et al.
Publicado: (2021)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction
por: Wan, Ying-Wooi, et al.
Publicado: (2010)

Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)

Repositioning Natural Products in Drug Discovery
por: Rastelli, Giulio, et al.
Publicado: (2020)

Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer
por: Ye, Qing, et al.
Publicado: (2023)

DrugCentral 2021 supports drug discovery and repositioning
por: Avram, Sorin, et al.
Publicado: (2020)

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)

Drug repositioning: Progress and challenges in drug discovery for various diseases
por: Hua, Yi, et al.
Publicado: (2022)

MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications
por: Slota, Jessy A., et al.
Publicado: (2019)

Drug repositioning can accelerate discovery of pharmacological chaperones
por: Hay Mele, Bruno, et al.
Publicado: (2015)

Large-scale Direct Targeting for Drug Repositioning and Discovery
por: Zheng, Chunli, et al.
Publicado: (2015)

A smoking-associated 7-gene signature for lung cancer diagnosis and prognosis
por: WAN, YING-WOOI, et al.
Publicado: (2012)

Multi-Walled Carbon Nanotube-Induced Gene Expression Biomarkers for Medical and Occupational Surveillance
por: Snyder-Talkington, Brandi N., et al.
Publicado: (2019)

Inferencing Bulk Tumor and Single-Cell Multi-Omics Regulatory Networks for Discovery of Biomarkers and Therapeutic Targets
por: Ye, Qing, et al.
Publicado: (2022)

Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019)

Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
por: Langhans, Sigrid A.
Publicado: (2018)

Application of microRNA Database Mining in Biomarker Discovery and Identification of Therapeutic Targets for Complex Disease
por: Major, Jennifer L., et al.
Publicado: (2020)

A Predictive 7-Gene Assay and Prognostic Protein Biomarkers for Non-small Cell Lung Cancer
por: Guo, Nancy Lan, et al.
Publicado: (2018)

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction
por: Coelho, Edgar D., et al.
Publicado: (2016)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

MicroRNA-Based Biomarkers in the Diagnosis and Monitoring of Therapeutic Response in Patients with Depression
por: Xu, Ya-Yun, et al.
Publicado: (2019)

From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures
por: Namba, Satoko, et al.
Publicado: (2022)

Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis
por: Kinnings, Sarah L., et al.
Publicado: (2009)

Systems-level biomarkers identification and drug repositioning in colorectal cancer
por: Beklen, Hande, et al.
Publicado: (2021)

The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells
por: PACURARI, MARICICA, et al.
Publicado: (2013)

A review on computer‐aided chemogenomics and drug repositioning for rational COVID‐19 drug discovery
por: Maghsoudi, Saeid, et al.
Publicado: (2022)

Human coronaviruses and therapeutic drug discovery
por: Song, Lan-Gui, et al.
Publicado: (2021)

siRNA Genome Screening Approaches to Therapeutic Drug Repositioning
por: Perwitasari, Olivia, et al.
Publicado: (2013)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer
por: Huang, Chien-Hung, et al.
Publicado: (2014)

Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020)

Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer
por: Al-Taie, Zainab, et al.
Publicado: (2021)

The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma
por: Zhu, Bingying, et al.
Publicado: (2018)

MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
por: Solly, Emma L., et al.
Publicado: (2019)

MicroRNA and diabetic retinopathy—biomarkers and novel therapeutics
por: Smit-McBride, Zeljka, et al.
Publicado: (2021)

The Role of microRNAs in Cancer: Functions, Biomarkers and Therapeutics
por: Tucci, Paola
Publicado: (2022)

MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2t88u5b68akl4lhg8an3vtu1rr